Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Cleary

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Arthritis and Rheumatism|February 2, 2012
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus CohortLouise Watson, Valentina Leone, Clarissa Pilkington, et al.
Rheumatology (Oxford, England)|March 18, 2025
The British Society for Rheumatology guideline for the management of foot health in inflammatory arthritisLara S Chapman, Michael Backhouse, Nadia Corp, et al.
Rheumatology (Oxford, England)|March 18, 2025
Executive Summary: The British Society for Rheumatology guideline for the management of foot health in inflammatory arthritisLara S Chapman, Michael Backhouse, Nadia Corp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 24, 2021
Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority TrialPaul A Brogan, Barbara Arch, Helen Hickey, et al.
Rheumatology (Oxford, England)|March 29, 2024
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritisHermine I Brunner, Nicolino Ruperto, Athimalaipet V Ramanan, et al.
Rheumatology (Oxford, England)|April 3, 2014
Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patientsDirekrit Chiewchengchol, Ruth Murphy, Thomas Morgan, et al.
Journal of Clinical Immunology|August 28, 2024
Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System InflammationClément Triaille, Neha Mohan Rao, Gillian I Rice, et al.
Rheumatology Advances in Practice|June 8, 2026
Holistic management of juvenile idiopathic arthritis across all ages: British Society for Rheumatology Guideline scopeSandrine Compeyrot-Lacassagne, Richard P Beesley, Lisa Bray, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Arthritis and Rheumatism|February 2, 2012
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus CohortLouise Watson, Valentina Leone, Clarissa Pilkington, et al.
Rheumatology (Oxford, England)|March 18, 2025
The British Society for Rheumatology guideline for the management of foot health in inflammatory arthritisLara S Chapman, Michael Backhouse, Nadia Corp, et al.
Rheumatology (Oxford, England)|March 18, 2025
Executive Summary: The British Society for Rheumatology guideline for the management of foot health in inflammatory arthritisLara S Chapman, Michael Backhouse, Nadia Corp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 24, 2021
Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority TrialPaul A Brogan, Barbara Arch, Helen Hickey, et al.
Rheumatology (Oxford, England)|March 29, 2024
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritisHermine I Brunner, Nicolino Ruperto, Athimalaipet V Ramanan, et al.
Rheumatology (Oxford, England)|April 3, 2014
Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patientsDirekrit Chiewchengchol, Ruth Murphy, Thomas Morgan, et al.
Journal of Clinical Immunology|August 28, 2024
Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System InflammationClément Triaille, Neha Mohan Rao, Gillian I Rice, et al.
Rheumatology Advances in Practice|June 8, 2026
Holistic management of juvenile idiopathic arthritis across all ages: British Society for Rheumatology Guideline scopeSandrine Compeyrot-Lacassagne, Richard P Beesley, Lisa Bray, et al.
Pageof 4